Previous Section | Index | Home Page |
Mrs. Brooke: To ask the Secretary of State for Health (1) how many cases of endometriosis have been treated within the Dorset health authority in the last 12 months; [10304]
(3) how many endometriosis cases there are within the Dorset health authority. [10305]
Ms Blears: The following figures are taken from the hospital episode statistics database, which contains details of patients admitted to and treated in national health service hospitals in England.
The number of finished consultant episodes for endometriosis treatment in hospitals in the Dorset health authority area for the 19992000 data year are as follows:
(ICD10 code N80).
(ICD10 code N80).
Information on cases of endometriosis referred abroad for treatment is not collected centrally.
Mr. Burns: To ask the Secretary of State for Health what has been (a) the total cost to the NHS of treatment under
30 Oct 2001 : Column: 655W
the concordat with the private sector, (b) the average cost of treatment per patient and (c) the average cost of similar treatment as in (b) above in the NHS. [10635]
Mr. Milburn: Contracts agreed under the concordat are signed at the local level and the Department does not have complete information on expenditure. £20 million was made available to the national health service to purchase treatment in the private sector last winter, which funded just over 10,500 cases, for example an average cost per case of approximately £1,900. However, in the absence of information on the mix of cases this figure is not particularly meaningful.
The Department has recently surveyed NHS health authorities and trusts on their use of the private sector. Analysis is not yet complete.
Mr. Burns: To ask the Secretary of State for Health what assessment he has made of the impact on delayed discharges in acute hospitals of treatment under the concordat with the private sector. [10490]
Mr. Milburn: Treatments provided under concordat arrangements will generally take patients off existing national health service waiting lists for elective surgery. I am not aware of any adverse impact on delayed discharges in acute hospitals as a result of patients receiving treatment under the concordat.
Mr. Burns: To ask the Secretary of State for Health how many patients have been treated under the concordat with the private sector since its implementation. [10492]
Mr. Milburn: Between 1 November 2000 and 30 September 2001 there were 64,136 national health service funded elective cases in the private sector.
Mr. Cousins: To ask the Secretary of State for Health what was the extent of bed blocking in each health authority and trust at the most recent available date; what was the basis on which the social services authorities with the most serious bed blocking problem, requiring extra priority allocations were identified; and for what reason the Newcastle city and North Tyneside borough social services authorities were not on the priority list. [10933]
Jacqui Smith: The latest figures on delayed discharges for each health authority and National Health Service trust are shown in the table. The decision on which councils should receive extra help was taken on the basis of the councils with the highest rate of delayed discharge and also councils, which the Department has identified as needing extra help through our performance monitoring arrangements. Newcastle city and North Tyneside borough social services did not meet these criteria.
30 Oct 2001 : Column: 658W
Mr. Havard: To ask the Secretary of State for Health what assessment he has received from the National Blood Service of the effect on the number of blood donors of testing for vCJD; and what plans he has to ensure the supply of blood to non-emergency patients who require transfusions as part of their treatments. [10718]
Mr. Hutton: The Department is currently working with the National Blood Service on contingency plans related to the screening of blood donors for vCJD and the impact this could have on the blood supply.
In parallel with the four United Kingdom Health Departments alongside the National Audit Office and the National Blood Transfusion Services, the UK Chief Medical Officers sponsored a conference on better blood transfusion on 29 October. The aim of the conference is to help set the priorities for blood transfusion in the national health service for the coming three to five years including the more efficient and effective use of blood so that we ensure the supply of blood to all patients who require transfusions as part of their treatment.